Ferumoxytol-enhanced Magnetic Resonance Imaging

Summary

There are no current alternatives to diagnostic contrast-requiring imaging for patients with an eGFR \<30mL/min due to the association of gadolinium-based imaging modalities to nephrogenic systemic fibrosis and iodinated contrast-induced kidney injury. Ferumoxytol-enhanced imaging may offer an alternative approach.

Timeline

Start

2015-01-01

Primary completion

2022-12-30

Completion

2022-12-30

Drugs

Indications